ONGC Videsh, alongwith with other public sector oil companies, has entered into an agreement to buy 49.5 percent stake in Russian oil firm Rosneft’s Vankorneft. The company has closed a deal to acquire 15 percent stake, says Narendra K Verma, MD & CEO of ONGC Videsh. Share purchase agreement (SPA) has been signed to acquire another 23.9 percent by a consortium led by Oil India , Indian Oil Corporation and Bharat PetroResources Limited (BPRL). “We are trying to augment our 15 percent stake with additional 11 percent,” says Verma adding that he is hopeful of closing the deal by September this year. Last year, ONGC Videsh produced 8.9 MMT, which is equivalent to 178 thousand barrels per day. In current fiscal, the company is aiming for 12 MMT production. Oil at higher level, close to USD 60 a barrel, will boost revenues. Verma is hopeful of doubling the production by 2018
Friday, 8 July 2016
Home »
» ONGC Videsh eyes additional 11% stake in Vankor field -:- Equity Research
ONGC Videsh eyes additional 11% stake in Vankor field -:- Equity Research
03:33
Related Posts:
Pokemon game adds $7.5 bn to Nintendo market value in two -:- Equity Research Shares in Japan's Nintendo Co Ltd soared again on Monday, bringing market-value gains to USD7.5 billion in just two days as investors cheered the runaway success of Pokemon GO - its first long-awaited venture in mobile … Read More
Sadbhav Engg sees cost of funds going down by Rs 70 cr in FY17 -:- Equity Research Speaking to CNBC-TV18 Nitin Patel of Sadbhav Engineering said that growth in tolling revenue and traffic are key triggers for the company. The company has completed refinancing 5 special purporse vehicles (SPVs) … Read More
India an outperformer among emerging markets -:- Equity Research Speaking to CNBC-TV18 Tim Condon of ING Financial Markets said that the US non-farm payroll data might come in at about 170,000. He also added that anything less than the 180,000 will be considered negative by the marke… Read More
Sudden rally in global equity markets momentary -:- Equity Research The huge gains in equity markets seen worldwide because of the nonfarm payroll data, which was announced in the US a few days ago, won't necessarily continue, said Geoff Lewis of Manulife Asset Management. He maintained t… Read More
llout of InfuSMART to begin with UK, Netherlands-:- Equity Research India's largest drug maker Sun Pharma began the rollout of its anti-cancer product ‘Gemcitabine InfuSMART’, a ready-to-administer bag for oncology treatment in six European countries. Talking about the above deve… Read More
0 comments:
Post a Comment